{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:19:10Z","timestamp":1783358350154,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"F\u00e9d\u00e9ration de recherche en infectiologie (F\u00e9RI) de la r\u00e9gion Centre"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.ejmech.2014.10.057","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T16:30:16Z","timestamp":1413995416000},"page":"386-400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activity"],"prefix":"10.1016","volume":"89","author":[{"given":"Esp\u00e9rance","family":"Moine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Denevault-Sabourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Debierre-Grockiego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Silpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Gorgette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Barale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Jacquiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Brossier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Gueiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dimier-Poisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Enguehard-Gueiffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.10.057_bib1","unstructured":"TDR: for Research on Diseases of Poverty. http:\/\/apps.who.int\/tdr\/."},{"key":"10.1016\/j.ejmech.2014.10.057_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/B978-0-444-52910-7.00028-3","article-title":"Congenital toxoplasmosis","volume":"112","author":"Kieffer","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/CMR.00001-10","article-title":"Importance of nonenteric protozoan infections in immunocompromised people","volume":"23","author":"Barratt","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2014.10.057_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vetpar.2011.05.031","article-title":"Neosporosis in animals-the last five years","volume":"180","author":"Dubey","year":"2011","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib6","first-page":"279","article-title":"Application of biotechnological tools for coccidia vaccine development","volume":"5","author":"Min","year":"2004","journal-title":"J.\u00a0Vet. Sci."},{"key":"10.1016\/j.ejmech.2014.10.057_bib7","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.2174\/092986712799828355","article-title":"Current advances in detection and treatment of babesiosis","volume":"19","author":"Mosqueda","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.057_bib8","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0021-9975(92)90039-W","article-title":"Neosporosis in the aborted fetus and newborn calf","volume":"107","author":"Ogino","year":"1992","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.4065\/mcp.2011.0203","article-title":"Antiparasitic therapy","volume":"86","author":"Kappagoda","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejmech.2014.10.057_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1365-3024.2010.01209.x","article-title":"Chasing the golden egg: vaccination against poultry coccidiosis","volume":"8","author":"Sharman","year":"2010","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetpar.2009.02.026","article-title":"Toxoplasmosis in sheep-the last 20 years","volume":"163","author":"Dubey","year":"2009","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejmech.2013.03.054","article-title":"3-Biphenylimidazo[1,2-a]pyridines or [1,2-b]pyridazines and analogues, novel Flaviviridae inhibitors","volume":"64","author":"Enguehard-Gueiffier","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.057_bib13","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.bmcl.2009.09.010","article-title":"Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors","volume":"19","author":"Qiao","year":"2009","journal-title":"Bioorg Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.10.057_bib14","series-title":"Preparation of Pyridazinone Derivatives as Calcilytics, From PCT Int. Appl.","author":"Shcherbakova","year":"2007"},{"key":"10.1016\/j.ejmech.2014.10.057_bib15","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0040-4020(00)00083-1","article-title":"A\u00a0new approach towards the synthesis of 3-Amino-6-(hetero)arylpyridazines based on palladium catalyzed cross-coupling reactions","volume":"56","author":"Maes","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.10.057_bib16","series-title":"Preparation of Triazolopyridinylmethylimidazopyridazinylcycylopropanecarboxamide Derivatives and Analogs for Use as cMET Inhibitors, From PCT Int. Appl.","author":"Bressi","year":"2010"},{"key":"10.1016\/j.ejmech.2014.10.057_bib17","series-title":"Imidazo[1,2-a]pyridines as Endothelial NO Synthase Expression Upregulators, their Preparation, Pharmaceutical Compositions, and Use in Therapy, From PCT Int. Appl.","author":"Zoller","year":"2008"},{"key":"10.1016\/j.ejmech.2014.10.057_bib18","author":"Chiang","year":"2010"},{"key":"10.1016\/j.ejmech.2014.10.057_bib19","series-title":"Derivatives of 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole, their Preparation, and their Therapeutic Application as Inhibitors of Casein Kinase 1 Epsilon and\/or Delta as well as Modulators of Circadian rhythm, From PCT Int. Appl.","author":"Oudot","year":"2010"},{"key":"10.1016\/j.ejmech.2014.10.057_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/1521-4184(200201)335:1<7::AID-ARDP7>3.0.CO;2-L","article-title":"Synthesis of imidazo[2,1-a]phthalazines, potential inhibitors of p38 MAP kinase. Prediction of binding affinities of protein ligands","volume":"335","author":"Mavel","year":"2002","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2014.10.057_bib21","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/j.1460-9568.2006.05043.x","article-title":"PIP3EA and PD- 168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain","volume":"24","author":"Melis","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejmech.2014.10.057_bib22","doi-asserted-by":"crossref","first-page":"9536","DOI":"10.1016\/j.bmc.2008.09.027","article-title":"Influence of 6- or 8-substitution on the antiviral activity of 3-arylalkylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (CMV) and varicella-zoster virus (VZV): part II","volume":"16","author":"V\u00e9ron","year":"2008","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.057_bib23","doi-asserted-by":"crossref","first-page":"7209","DOI":"10.1016\/j.bmc.2007.03.061","article-title":"Influence of 6 or 8-substitution on the antiviral activity of 3- phenethylthiomethylimidazo[1,2-a]pyridine against human cytomegalovirus (HCMV) and varicella-zoster virus (VZV)","volume":"15","author":"V\u00e9ron","year":"2007","journal-title":"Bioorg Med. Chem."},{"key":"10.1016\/j.ejmech.2014.10.057_bib24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1128\/AAC.41.9.1849","article-title":"Use of Toxoplasma gondii expressing beta-galactosidase for colorimetric assessment of drug activity in\u00a0vitro","volume":"41","author":"McFadden","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.10.057_bib25","series-title":"Essentials of Veterinary Parasitology","first-page":"96","author":"Elsheikha","year":"2011"},{"key":"10.1016\/j.ejmech.2014.10.057_bib26","first-page":"1","article-title":"A\u00a0review on bovine besnoitiosis: a disease with economic impact in herd health management, caused by Besnoitia besnoiti (Franco and Borges, 1916)","author":"Cortes","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.ejmech.2014.10.057_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ja.2005.90","article-title":"FR177391, a new anti-hyperlipidemic agent from Serratia. IV. Target identification and validation by chemical genetic approaches","volume":"58","author":"Yamaoka","year":"2005","journal-title":"J.\u00a0Antibiot."},{"key":"10.1016\/j.ejmech.2014.10.057_bib28","series-title":"Biotechnology \u2013 Guidelines on Techniques in Coccidiosis Research","first-page":"1","article-title":"Eimeria species and strains of chicken","author":"Shirley","year":"1995"},{"key":"10.1016\/j.ejmech.2014.10.057_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.vetpar.2013.04.020","article-title":"Parasiticidal activity of a novel synthetic peptide from the core \u03b1-helical region of NK-lysin","volume":"197","author":"Lee","year":"2013","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.ejmech.2014.10.057_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/AAC.16.6.710","article-title":"Quantitative assessment of antimalarial activity in\u00a0vitro by a semiautomated microdilution technique","volume":"16","author":"Desjardins","year":"1979","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.10.057_bib31","doi-asserted-by":"crossref","first-page":"18561","DOI":"10.1074\/jbc.M113.456764","article-title":"In Silico screening on the three-dimensional model of the Plasmodium vivax SUB1 protease leads to the validation of a novel anti-parasite compound","volume":"288","author":"Bouillon","year":"2013","journal-title":"J.\u00a0Biol. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414009854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T07:46:05Z","timestamp":1717487165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414009854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":31,"alternative-id":["S0223523414009854"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.057","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small-molecule cell-based screen led to the identification of biphenylimidazoazines with highly potent and broad-spectrum anti-apicomplexan activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}